Loading insider details...
Beta
Latest Form 4 (Jul 16, 2026): Purchase of 687,285 CRDF shares, $1000.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 16, 2026 | Cardiff Oncology, Inc. (CRDF) | Purchase | 687,285 | $1000.0K |
| Jun 22, 2026 | Cardiff Oncology, Inc. (CRDF) | Purchase | 30,000 | $36.6K |
| Jun 16, 2026 | Cardiff Oncology, Inc. (CRDF) | Grant/Award | 40,565 | n/a |
| Jul 31, 2025 | Cardiff Oncology, Inc. (CRDF) | Purchase | 275,000 | $673.8K |
| Jun 27, 2025 | Cardiff Oncology, Inc. (CRDF) | Grant/Award | 40,565 | n/a |
| Dec 12, 2024 | Cardiff Oncology, Inc. (CRDF) | Purchase | 350,115 | $910.3K |
| Jul 1, 2024 | Cardiff Oncology, Inc. (CRDF) | Grant/Award | 29,700 | n/a |
| Mar 8, 2024 | Pacira BioSciences, Inc. (PCRX) | Sale | 1,066 | $31.6K |
| Dec 19, 2023 | Cardiff Oncology, Inc. (CRDF) | Purchase | 30,000 | $41.1K |
| Nov 14, 2023 | Cardiff Oncology, Inc. (CRDF) | Purchase | 22,950 | $22.5K |